课题基金 / 基金详情

Identification and analysis of tyrosine phosphatase CD45 interacting proteins

Identification and analysis of tyrosine phosphatase CD45 interacting proteins
酪氨酸磷酸酶 CD45 相互作用蛋白的鉴定和分析
批准号:
09680653
负责人:
FURUKAWA Tatsuhiko
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

FURUKAWA Tatsuhiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
CD45 and leukocyte common antigen-related protein(LAR) have two tandem-repeated PTPase domains in the cytoplasmic segment like most of other transmembrane protein tyrosine phosphatases (RTPases). PTPase activity is associated only with the first of the two domains, PTPase domain 1(D1), and the membrane-distal PTPase domain 2(D2), which has no catalytic activity, would regulate substrate specificity.From the lysate of co-expression of CD3zeta, lck and CD45D1CS, whose cystein at 828 has replaced with serine, phosphorylated CD3zeta was coprecipitated with CD45D1CS using anti-CD45 antibody. This finding indicates CD3zeta is a good substrate of CD45 also in vivo. Three kinds mutants MC1, MC2, MC3 of CD3zeta, which are carrying only 2 tyrosine residues, 2nd and 3rd, 1st and 3rd, 1st and 2nd tyrosine from C terminus, were made. All 3 mutants can be poorly phosphorylated with Ick and has almost same affinty with CD45D1CS, but SHC-SH2 can not bind with phosphorylated MC2 mutant.CD45D1D2CS, whose cystein at 1144 was replaced with serine, has lower affinity with CD3zeta, and phsophorylated CD3zeta than CD45D1CS.Cystein of D2 has an important role of recognition of CD3zeta, independently of phosphorylation.We studied on LAR and insuline receptor (IR) interaction also. LAR was associated with and preferentially dephosphorylated the insulin receptor which was tyrosine-phosphorylated after insulin stimulation. LARD1CS can bind phosphorylated IR stably. IR can be a phsiological substrate of LAR.LAR is phsophorylated with IRkinase after insuline stimulation. LARD1D2CS , whose cystein 1813 is changed to serine in the domain 2, has lower affinity with IR and higher phosphrylation than LARDICS.These findings suggests LARD2 has auto-dephosphorylation activity. These data indicate that D1PTP of CD45 and LAR has main phosphatase activity and D2 PTP of them can recognize the substrates independently of phosphorylation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tomoyuki Sumizawa: "Reversal of MRP-associated drug resistance by the pyridine analog, PAK-104P" Mol.Pharmacol.51. 399-405 (1997)
Tomoyuki Sumizawa:“吡啶类似物 PAK-104P 逆转 MRP 相关耐药性”Mol.Pharmacol.51。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yuji Takebayashi, Shin-ichi Akiyama, Shoji Natsugoe, Shuichi Hokita, Kiyoshi Niwa, Masaki Kitazono, Tomoyuki Sumizawa, Misako Haraguchi, Tatsuhiko Furukawa, Shuichi Nagayama and Takeshi Aikou: "The expression of multidrug resistance protein (MRP) in human
Yuji Takebayashi、Shin-ichi Akiyama、Shoji Natsugoe、Shuichi Hokita、Kiyoshi Niwa、Masaki Kitazono、Tomoyuki Sumizawa、Misako Haraguchi、Tatsuhiko Furukawa、Shuichi Nagayama 和 Takeshi Aikou:“人类多药耐药蛋白 (MRP) 的表达
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tomoyuki Sumizawa: "Reversal of MRP-associated drug resistance by the pyridine analog,PAK-104P" Molecular Pharmacology. 51. 399-405 (1997)
Tomoyuki Sumizawa:“吡啶类似物 PAK-104P 逆转 MRP 相关耐药性”分子药理学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Zhe-Sheng Chen: "An active efflux system for heavy metals in cisplatin-resistant human KB carcinoma cells" Experimental Cell Research. (発表予定). (1998)
Zhe-Sheng Chen:“抗顺铂人类 KB 癌细胞中重金属的主动外排系统”实验细胞研究(即将发表)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
35
    Analysis of cooperative functions of transporters andvesicle transport system in efflux of anticancer agents
    • 批准号:
      22501047
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2010
    • 负责人:
      FURUKAWA Tatsuhiko
    • 依托单位:
    Nano-scale analysis of the drug transport mechanism of MRP1
    • 批准号:
      17590272
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2005
    • 负责人:
      FURUKAWA Tatsuhiko
    • 依托单位:
    Analysis of substrates transport mechanism and structural modification of MRP1
    • 批准号:
      14570123
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2002
    • 负责人:
      FURUKAWA Tatsuhiko
    • 依托单位:
    Analysis of the mechanisms for biological activities of thymidine phosphorylase
    • 批准号:
      12670144
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2000
    • 负责人:
      FURUKAWA Tatsuhiko
    • 依托单位:
    国内基金
    海外基金
    循环肿瘤细胞通过获得CD45逃避T细胞的抗肿瘤免疫及促进肿瘤转移的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      王雪萍
    • 依托单位:
    TGF-β降解TAL1在EPOR缺失导致荷瘤状态下CD45阳性红系前体细胞分化阻滞中的作用及机制
    CD45 PTPs对脓毒症T细胞亚群分化调控机制及黄芪皂苷干预作用的研究
    • 批准号:
      81960745
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      34.0万元
    • 批准年份:
      2019
    • 负责人:
      万春平
    • 依托单位:
    反义非编码RNA调控淋巴细胞CD45亚型表达的研究
    • 批准号:
      31870745
    • 项目类别:
      面上项目
    • 资助金额:
      59.0万元
    • 批准年份:
      2018
    • 负责人:
      苏中静
    • 依托单位: